申请人:CADILA HEALTHCARE LIMITED
公开号:US20150307540A1
公开(公告)日:2015-10-29
The invention provides an amorphous form of dapagliflozin 1,2-propanediol of Formula (A) or hydrates thereof and their process for preparation. The present invention also provides a pharmaceutical composition comprising art amorphous solid dispersion containing dapagliflozin 1,2-propanediol or hydrates thereof.
本发明提供了一种Formula(A)的达格列净1,2-丙二醇非晶态形式或其水合物以及它们的制备方法。本发明还提供了一种制药组合物,其中包含达格列净1,2-丙二醇或其水合物的非晶态固体分散体。